SB-743921

DRUG2 trials

Sponsors

GlaxoSmithKline, Cytokinetics

Conditions

Hodgkin's DiseaseNon-Hodgkin's LymphomaSolid Tumor Cancer

Phase 1

SB-743921 In Patients With Solid Tumors

CompletedNCT00136513

GlaxoSmithKlineSolid Tumor Cancer

Start: 2004-04-30Updated: 2008-10-16

A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma

CompletedNCT00343564

CytokineticsHodgkin's Disease, Non-Hodgkin's Lymphoma

Start: 2006-04-30End: 2010-07-31Updated: 2020-01-13